Skip to content
naulon
Get started

Corrected on Aug 17, 2023.

Source: the publisher, via Crossref · checked Oct 20, 2026 · Read the notice (opens in a new tab)

APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease

Aivi T. Nguyen, Kui Wang, Gang Hu and 9 more (opens in a new tab)

Acta Neuropathologica · 2020

doi:10.1007/s00401-020-02200-3 (opens in a new tab)

References 76

  1. 1.
    Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 · 2016
    Corrected
  2. 2.

    Scheff SW and Price DA, Synapse loss in the temporal lobe in Alzheimer’s disease. Ann Neurol, 1993 33(2): p. 190–199.

    Not in our library10.1002/ana.410330209 (opens in a new tab)

  3. 3.

    Terry RD,, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol, 1991 30(4): p. 572–80.

    Not in our library10.1002/ana.410300410 (opens in a new tab)

  4. 4.

    Glenner GG and Wong CW, Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and biophysical research communications, 1984 120(3): p. 885–90.

    Not in our library10.1016/s0006-291x(84)80190-4 (opens in a new tab)

  5. 5.

    Thal DR,, Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology, 2002 58(12): p. 1791–1800.

    Not in our library10.1212/wnl.58.12.1791 (opens in a new tab)

  6. 6.

    Lambert JC,, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nature genetics, 2013 45(12): p. 1452–8.

    Not in our library10.1038/ng.2802 (opens in a new tab)

  7. 7.
    Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk · 2017
    No notice
  8. 8.

    Guerreiro R,, TREM2 Variants in Alzheimer’s Disease. New England Journal of Medicine, 2012 368(2): p. 117–127.

    Not in our library10.1056/nejmoa1211851 (opens in a new tab)

  9. 9.

    Jonsson T,, Variant of TREM2 Associated with the Risk of Alzheimer’s Disease. New England Journal of Medicine, 2012 368(2): p. 107–116.

    Not in our library10.1056/nejmoa1211103 (opens in a new tab)

  10. 10.

    Kunkle BW,, Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nature genetics, 2019 51(3): p. 414–430.

    Not in our library10.1038/s41588-019-0358-2 (opens in a new tab)

  11. 11.

    Neu SC,, Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurology, 2017 74(10): p. 1178–1189.

    Not in our library10.1001/jamaneurol.2017.2188 (opens in a new tab)

  12. 12.

    Sims R,, Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nature Genetics, 2017 49(9): p. 1373–1384.

    Not in our library10.1038/ng.3916 (opens in a new tab)

  13. 13.

    Kleinberger G,, TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med, 2014 6(243): p. 243ra86.

    Not in our library10.1126/scitranslmed.3009093 (opens in a new tab)

  14. 14.

    Keren-Shaul H,, A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease. Cell, 2017 169(7): p. 1276–1290.e17.

    Not in our library10.1016/j.cell.2017.05.018 (opens in a new tab)

  15. 15.
    Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders · 2016
    No notice
  16. 16.

    Kim J, Basak JM, and Holtzman DM, The Role of Apolipoprotein E in Alzheimer’s Disease. Neuron, 2009 63(3): p. 287–303.

    Not in our library10.1016/j.neuron.2009.06.026 (opens in a new tab)

  17. 17.

    Mauch DH,, CNS synaptogenesis promoted by glia-derived cholesterol. Science, 2001 294(5545): p. 1354–7.

    Not in our library10.1126/science.294.5545.1354 (opens in a new tab)

  18. 18.

    Pfrieger FW, Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci, 2003 60: p. 1158–1171.

    Not in our library10.1007/s00018-003-3018-7 (opens in a new tab)

  19. 19.

    Grehan S, Tse E, and Taylor JM, Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain. Journal of Neuroscience, 2001 21(3): p. 812–822.

    Not in our library10.1523/jneurosci.21-03-00812.2001 (opens in a new tab)

  20. 20.

    Mahley RW, Weisgraber KH, and Huang Y, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 2006 103(5): p. 5644–5651.

    Not in our library10.1073/pnas.0600549103 (opens in a new tab)

  21. 21.

    Ulrich JD,, ApoE facilitates the microglial response to amyloid plaque pathology. The Journal of Experimental Medicine, 2018 215(4): p. 1047–1058.

    Not in our library10.1084/jem.20171265 (opens in a new tab)

  22. 22.

    Sala Frigerio C,, The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques. Cell Reports, 2019 27(4): p. 1293–1306.e6.

    Not in our library10.1016/j.celrep.2019.03.099 (opens in a new tab)

  23. 23.

    Zhao Y,, TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function. Neuron, 2018 97(5): p. 1023–1031.e7.

    Not in our library10.1016/j.neuron.2018.01.031 (opens in a new tab)

  24. 24.

    Toledo JB,, A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 2014 10(4): p. 477–484 e1.

    Not in our library10.1016/j.jalz.2013.06.003 (opens in a new tab)

  25. 25.
    SCANPY: large-scale single-cell gene expression data analysis · 2018
    No notice
  26. 26.

    Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E, Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment, 2008 2008(10).

    Not in our library

  27. 27.

    Jakel S,, Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature, 2019 566(7745): p. 543–547.

    Not in our library10.1038/s41586-019-0903-2 (opens in a new tab)

  28. 28.

    Mi H,, Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nature protocols, 2019 14(3): p. 703–721.

    Not in our library10.1038/s41596-019-0128-8 (opens in a new tab)

  29. 29.
    Cell-specific network constructed by single-cell RNA sequencing data · 2019
    No notice
  30. 30.
    MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions · 2019
    No notice
  31. 31.

    Liu F,, Global spectral clustering in dynamic networks. Proceedings of the National Academy of Sciences of the United States of America, 2018 115(5): p. 927–932.

    Not in our library10.1073/pnas.1718449115 (opens in a new tab)

  32. 32.

    Trapnell C,, The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nature Biotechnology, 2014 32: p. 381.

    Not in our library10.1038/nbt.2859 (opens in a new tab)

  33. 33.
    ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software · 2014
    No notice
  34. 34.
    The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 · 2018
    No notice
  35. 35.
    QuPath: Open source software for digital pathology image analysis · 2017
    No notice
  36. 36.

    Jack CR Jr, Bennett DA, Blennow K, NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562

    Not in our library10.1016/j.jalz.2018.02.018 (opens in a new tab)

  37. 37.
    Deep learning enables accurate clustering with batch effect removal in single-cell RNA-seq analysis · 2020
    No notice
  38. 38.

    Streit WJ,, Dystrophic microglia in the aging human brain. Glia, 2004 45(2): p. 208–212.

    Not in our library10.1002/glia.10319 (opens in a new tab)

  39. 39.

    Lopes KO, Sparks DL, and Streit WJ, Microglial dystrophy in the aged and Alzheimer’s disease brain is associated with ferritin immunoreactivity. Glia, 2008 56(10): p. 1048–1060.

    Not in our library10.1002/glia.20678 (opens in a new tab)

  40. 40.

    Kristiansen M,, Identification of the haemoglobin scavenger receptor. Nature, 2001 409(6817): p. 198–201.

    Not in our library10.1038/35051594 (opens in a new tab)

  41. 41.

    Cao J,, The single-cell transcriptional landscape of mammalian organogenesis. Nature, 2019 566(7745): p. 496–502.

    Not in our library10.1038/s41586-019-0969-x (opens in a new tab)

  42. 42.

    Qiu X,, Single-cell mRNA quantification and differential analysis with Census. Nature Methods, 2017 14: p. 309.

    Not in our library10.1038/nmeth.4150 (opens in a new tab)

  43. 43.
    PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells · 2019
    No notice
  44. 44.

    Deming Y,, The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk. Science translational medicine, 2019 11(505).

    Not in our library10.1126/scitranslmed.aau2291 (opens in a new tab)

  45. 45.

    Krasemann S,, The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity, 2017 47(3): p. 566–581.e9.

    Not in our library10.1016/j.immuni.2017.08.008 (opens in a new tab)

  46. 46.

    Prokop S, Miller KR, Labra SR, Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer’s disease patient brain samples. Acta Neuropathol. 2019;138(4):613–630.

    Not in our library10.1007/s00401-019-02048-2 (opens in a new tab)

  47. 47.

    Gjoneska E,, Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease. Nature, 2015 518(7539): p. 365–369.

    Not in our library10.1038/nature14252 (opens in a new tab)

  48. 48.

    Heneka MT, Golenblock DT, and Latz E, Innate Immunity in Alzheimer’s disease. Nature Immunology, 2010 16(3): p. 229–236.

    Not in our library10.1038/ni.3102 (opens in a new tab)

  49. 49.
    Microglial subtypes: diversity within the microglial community · 2019
    No notice
  50. 50.

    del Rio-Hortega P, El “Tercer Elemento de los Centros Nerviosos”. IV. Poder Fagocitario y Movilidad de la Microglía. Boletín de la Sociedad Española de Biología VIII, 1919: p. 154–171.

    Not in our library

  51. 51.

    Sierra A, Paolicelli RC, and Kettenmann H, Cien Anos de Microglia: Milestones in a Century of Microglial Research. Trends in Neurosciences, 2019 42(11): p. 778–792.

    Not in our library10.1016/j.tins.2019.09.004 (opens in a new tab)

  52. 52.

    Mathys H,, Single-cell transcriptomic analysis of Alzheimer’s disease. Nature, 2019 570(7761): p. 332–337.

    Not in our library10.1038/s41586-019-1195-2 (opens in a new tab)

  53. 53.

    Kodama L, Guzman E, Etchegaray JI, Microglial microRNAs mediate sex-specific responses to tau pathology. Nat Neurosci. 2020; 23(2):167–171

    Not in our library10.1038/s41593-019-0560-7 (opens in a new tab)

  54. 54.

    Zhao N, Ren Y, Yamazaki Y, Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways. Neuron. 2020;106(5):727–742.e6

    Not in our library10.1016/j.neuron.2020.02.034 (opens in a new tab)

  55. 55.

    Zhou Y,, Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Nature Medicine, 2020 26: p. 131–142.

    Not in our library10.1038/s41591-019-0695-9 (opens in a new tab)

  56. 56.

    Gordon S Homeostasis: a scavenger receptor for haemoglobin. Curr Biol. 2001;11(10):R399–R401

    Not in our library10.1016/s0960-9822(01)00218-4 (opens in a new tab)

  57. 57.

    Sarrias MR, Grønlund J, Padilla O, Madsen J, Holmskov U, Lozano F. The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol. 2004;24(1):1–37

    Not in our library10.1615/critrevimmunol.v24.i1.10 (opens in a new tab)

  58. 58.

    Kristiansen M, Graversen JH, Jacobsen C, Identification of the haemoglobin scavenger receptor. Nature. 2001;409(6817):198–201

    Not in our library10.1038/35051594 (opens in a new tab)

  59. 59.

    Bover LC, Cardó-Vila M, Kuniyasu A, A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol. 2007;178(12):8183–8194

    Not in our library10.4049/jimmunol.178.12.8183 (opens in a new tab)

  60. 60.

    Kneidl J, Löffler B, Erat MC, Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cell Microbiol. 2012;14(6):914–936

    Not in our library10.1111/j.1462-5822.2012.01766.x (opens in a new tab)

  61. 61.

    Roberts ES, Masliah E, Fox HS. CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol. 2004;63(12):1255–1264

    Not in our library10.1093/jnen/63.12.1255 (opens in a new tab)

  62. 62.

    Pey P, Pearce RK, Kalaitzakis ME, Griffin WS, Gentleman SM. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease. Acta Neuropathol Commun. 2014;2:21 Published 2014 Feb 14

    Not in our library10.1186/2051-5960-2-21 (opens in a new tab)

  63. 63.

    Galea J, Cruickshank G, Teeling JL, The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage. J Neurochem. 2012;121(5):785–792

    Not in our library10.1111/j.1471-4159.2012.07716.x (opens in a new tab)

  64. 64.

    Yu H, Liu X, Zhong Y. The Effect of Osteopontin on Microglia. Biomed Res Int. 2017;2017:1879437

    Not in our library10.1155/2017/1879437 (opens in a new tab)

  65. 65.

    Shin YJ, Kim HL, Choi JS, Choi JY, Cha JH, Lee MY. Osteopontin: correlation with phagocytosis by brain macrophages in a rat model of stroke. Glia. 2011;59(3):413–423

    Not in our library10.1002/glia.21110 (opens in a new tab)

  66. 66.

    Uchihara T, Duyckaerts C, He Y, ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain. Neurosci Lett. 1995;195(1):5–8

    Not in our library10.1016/0304-3940(95)11763-m (opens in a new tab)

  67. 67.
    A transcriptomic atlas of aged human microglia · 2018
    No notice
  68. 68.
    Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins · 2018
    No notice
  69. 69.

    Polazzi E, Mengoni I, Peña-Altamira E, Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology. J Neuropathol Exp Neurol. 2015;74(8):818–834

    Not in our library10.1097/nen.0000000000000222 (opens in a new tab)

  70. 70.

    Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1–40. J Neurosci. 2006;26(12):3345–3356

    Not in our library10.1523/jneurosci.5186-05.2006 (opens in a new tab)

  71. 71.

    Saura J, Petegnief V, Wu X, Liang Y, Paul SM. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J Neurochem. 2003;85(6):1455–1467

    Not in our library10.1046/j.1471-4159.2003.01788.x (opens in a new tab)

  72. 72.

    Mori K, Yokoyama A, Yang L, L-serine-mediated release of apolipoprotein E and lipids from microglial cells. Exp Neurol. 2004;185(2):220–231

    Not in our library10.1016/j.expneurol.2003.10.010 (opens in a new tab)

  73. 73.

    Lue LF, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG. TREM2 Protein Expression Changes Correlate with Alzheimer’s Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices. Brain Pathol. 2015;25(4):469–480

    Not in our library10.1111/bpa.12190 (opens in a new tab)

  74. 74.

    Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques. Nat Commun. 2015;6:6176 Published 2015 Jan 29

    Not in our library10.1038/ncomms7176 (opens in a new tab)

  75. 75.

    Mehta D,, Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010–2015. Expert Opin Investig Drugs, 2017 26(6): p. 735–739.

    Not in our library10.1080/13543784.2017.1323868 (opens in a new tab)

  76. 76.

    Hardy J and Selkoe D, The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science, 2002 297: p. 353–356.

    Not in our library10.1126/science.1072994 (opens in a new tab)

Cited by papers we hold 17

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.